Shalini Kumari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Shalini Kumari has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Rikeshwer Prasad Dewangan
Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research (SPER), Jamia Hamdard (Deemed to be University), New Delhi 110062, India
2 shared publications Afeefa Noor
Lloyd Institute of Management and Technology, Knowledge Park-II, Greater Noida, Uttar Pradesh – 201306, India
1 shared publicationAman Kumar Mahto
1 shared publicationAmulya K. Panda
1 shared publication- Arvind Kumar Singh Chandel
Bernal Institute, university of Limerick
1 shared publication Bahar Ahmed
Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard (Deemed to be University), New Delhi – 110062, India
1 shared publication
Latest Publications
- Open Access
- 1 January 2027
- Published by Royal Society of Chemistry (RSC) in RSC Pharmaceutics
Indole–hydrazone hybrid derivatives as emerging therapeutics for enhanced skin cancer therapy: molecular design, biological evaluation and nanoliposomal delivery
To advance skin cancer therapeutics, a series of indole–hydrazone derivatives (5a–5l) was synthesized via the hydrazone condensation reaction and formulation development of 5l -based nanoliposomal gel (GEL4).
- 1 January 2027
- Published by Royal Society of Chemistry (RSC) in RSC Pharmaceutics
Open AccessIndole–hydrazone hybrid derivatives as emerging therapeutics for enhanced skin cancer therapy: molecular design, biological evaluation and nanoliposomal delivery
To advance skin cancer therapeutics, a series of indole–hydrazone derivatives (5a–5l) was synthesized via the hydrazone condensation reaction and formulation development of 5l -based nanoliposomal gel (GEL4).
- 11 September 2022
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 76
Augmented therapeutic efficacy of Gemcitabine conjugated self-assembled nanoparticles for cancer chemotherapy
- 11 September 2022
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 76
Augmented therapeutic efficacy of Gemcitabine conjugated self-assembled nanoparticles for cancer chemotherapy